Plné znění - 2/2008 Sb. m. s.

Ministerstvo xxxxxxxxxxxx xxxx xxxxxxx, xx xxx 16. xxxxxxxxx 2007 xxxx generálním xxxxxxxxx XXXXXX, depozitářem Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx ve sportu¹⁾, xxxxxxxx schválení nového xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x xxxxx xxxxxxx.

Xxxxxxx X vstoupila x xxxxxxxx v xxxxxxx s článkem 34 xxxx. 3 Úmluvy xxx 1. xxxxx 2008 x tímto xxxx xxxxxxxxx x xxxxxxxx i xxx Xxxxxx xxxxxxxxx. Dnem xxxxxx Xxxxxxx I x xxxxxxxx xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx úmluvy proti xxxxxxx ve xxxxxx xx znění pro xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. x.

Xxxxxxxx znění Xxxxxxx X x xxxx xxxxxxx xx xxxxxxx xxxxxx xx vyhlašují xxxxxxxx.

X1. ANABOLICKÉ XXXXX

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. ANDROGENNÍ XXXXXXXXXX XXXXXXXX (XXX):

x. Exogenní * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-norandrostendiol); xxxxxxxxxx; xxxxxxxx; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); desoxymethyltestosteron (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-hydroxytestosteron (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); kalusteron; klostebol; xxxxxxxxxx; xxxxxxxxxx; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; methandriol; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); methyl-1-testosteron (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); methylnortestosteron (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; nandrolon; 19-norandrostendion (xxxx-4-xx-3,17-xxxx); norboleton; norethandrolon; xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); quinbolon; xxxxxxxxxx; xxxxxxxxx; 1-xxxxxxxxxxx (17β-hydroxy-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); trenbolon x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), androstendion (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), xxxxxxxxxxx x xxxxxxxxxxx metabolity x xxxxxxx:

5α-androstan-3α,17α-diol androst-5-en-3β,17α-diol

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (androst-4-en-3β,17β-diol)

5α-androstan-3β,17α-diol 5-androstendion (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

androst-4-en-3α,17α-diol 3α-hydroxy-5αandrostan-17-on

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

V xxxxxxxxx, xxx xxxx xxxx xxxxxxxxxx androgenní xxxxxxxxxx steroid přirozeně, xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx xxxx Xxxxxxxxx látku x xxxx xxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx nález, xxxx xx koncentrace Xxxxxxxx látky nebo xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx x/xxxx xxxx xx jakýkoli jiný xxxxxxxxx poměr xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx od rozmezí xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx u xxxx tak, xx xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx. Xxxxxx xx xxx xx xx, xx Vzorek xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xx xxxxxxxxxxx Xxxxxxxx xxxxx nebo jejích xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx fyziologickým nebo xxxxxxxxxxxx stavem.

Xxxx xx xxx za xx, xx Vzorek Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx ve xxxxx xxxxxxxxx x při xxxxxxxxx koncentraci, xxxxx xxx podle xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxx, xx xx Xxxxxxxx látka xxxxxxxxxx xxxxxx. X xxxxxxx xxxxxxx xxxx xxxxx provádět další xxxxxxx.

Když xx xxxxxxx výsledku analýzy xxxxxxxx neodchylují od xxxxxxx hodnot, xxxxx xx normálně vyskytují x xxxx a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx, jako xxxx. porovnání x xxxxxxxxxxx referenčními xxxxxxxxxxx xxxxxxx, nebo xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx xxx xxxxx (4) xx xxxxx (1) x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx, xxxxxxx příslušná Xxxxxxxxxxxxx organizace xxxxx xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx testů xxxx xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, xxx xxxxxxxx xxxx laboratoří xxxxxx jako xxxxxxxxx x xx xxxx xxxxxxxxx. Pokud xxxxxxxxx xxxxxxx, za xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx nutné xxxxxxxx xxxxx xxxxxxx, x xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx. Xxxxx xxxxxx xxxxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. XXXX) x xxxxxx k xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx xxx, xx xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxx 3 měsících třikrát xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Výsledek, xxxxx xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, bude xxxxxx xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx profil Sportovce, xxxxxxxx xxxxxxxxxx testy, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx xx xxx xxxxxxxxx xx Pozitivní xxxxxxxxxxx nález.

X xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx xxx x xxxx xxxxxx xxxxxxx boldenon endogenního xxxxxx ve xxxxxx xxxxxx xxxxxxxxxxxxx (xx/xx). Xxxxx laboratoř takový xxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxx analytické xxxxxx (xxxx. XXXX) xxxxxxxxxxx exogenní xxxxx Xxxxxxxx látky, xxxx xxx provedeno xxxxx xxxxxxx provedením xxxxxxxxxx xxxxx (xxxxxxxxxx testů).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx nález 19-xxxxxxxxxxxxxxx, xxxx xx xx xxxxxxxxx xx xxxxxxx a xxxxxxxxxxx xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. X xxxxxxx xxxxxxx xxxx xxxxx provádět xxxxx xxxxxxx.

V xxxxxxx, xx Xxxxxxxxx nebude xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, xxxx xx xxx xx xx, xx Vzorek Xxxxxxxxx xxxxxxxx Zakázanou látku.

2. Xxxxxxx anabolické xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), tibolon, xxxxxxx, zilpaterol, xxx xx x xxxxxxxx xxxxx xx xx.

S2. XXXXXXX X PŘÍBUZNÉ XXXXX

Xxxxxxxxxxx látky x jejich xxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxxxx (XXX);

2. Xxxxxxx xxxxxx (xXX), xxxxxxxx xxxxxxx xxxxxxx faktory (xxxx. XXX-1), mechanické xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (xxxx. XX, xXX), xxxxxxxx xxx x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Pokud Xxxxxxxxx xxxxxx prokázat, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx xxxxxx, xxxx xx xxx za xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx (xxx je xxxxxxx xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx či xxxxxxxxxx x/xxxx příslušné xxxxxx xx Xxxxxx Xxxxxxxxx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxx x xxxx xxx, že xxxxxxxxxxxx normální xxxxxxxxx xxxxxxxx.

Pokud laboratoř xxxxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Zakázaná xxxxx xx xxxxxxxxxx xxxxxx, xxxx se xxx xx to, xx Xxxxxx obsahuje Zakázanou xxxxx a bude xxxxxxx Pozitivní laboratorní xxxxx.

S3. XXXX-2 XXXXXXXX

Xxxxxxx xxxx-2 xxxxxxxx xxxxxx xxxxxx X- x X-xxxxxxx jsou zakázáni.

Xxxxxxxx xxxx formoterol, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, xxx xxxxx xx xxx xxxxxxxx xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx výjimky.

X xxxx byla udělena xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxx, xxxx xxxxx xxxxxxxxxxx (volný xxxx xxxxxxxxxx) xxxxx než 1000 xxxxxxxxx v 1 mililitru xxxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx výsledek xxx xxxxxxxx terapeutickým xxxxxxxx xxxxxxxxxxx x inhalaci.

S4. ANTAGONISTÉ X XXXXXXXXXX HORMONŮ

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Inhibitory xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx látky xxxxxxxxxx:

4. Xxxxx modifikující xxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, ale xx x xxxxxxxx xxxxx xx ně.

X5. XXXXXXXXX A XXXXXXX XXXXXXXXX XXXXX

Xxxxxxxxx látky xxxx xxxxxxxx. Zahrnují:

Xxxxxxxxx*, xxxxxxxxxxxxxx, probenecid, xxxxxxxxxx alfa-reduktázy (xxxx. xxxxxxxxxx, xxxxxxxxxx), plasmaexpandery (xxxx. albumin, dextran, xxxxxxxxxxxxxxxxx) x xxxxx xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, chlortalidon, xxxxxxxxx, xxxxxxxx, kyselina xxxxxxxxxx, metolazon, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, chlorothiazid), xxxxxxxxxx x další xxxxx x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky (xxxxx xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx).

* Terapeutická xxxxxxx xxxx xxxxxx, xxxxx xxx Sportovce xxxxxxxx xxxxxxxxx ve xxxxxxx x prahovou xxxx podprahovou xxxxxxxx xxxx Xxxxxxxx xxxxx (xxxxx).

X1. XXXXXXXXX PŘENOSU XXXXXXX

Xxxxxxxx je xxxxxxxxxxx:

X2. XXXXXXXX X XXXXXXXXX MANIPULACE

X3. XXXXXX DOPING

Neterapeutické xxxxxxx xxxxx, xxxx, xxxxxxxx elementů, xxxx xxxxxxxxxx exprese xxxx, xxxxx xxxx xxxxxxxxx xxxxxx sportovní xxxxx, xx xxxxxxxx.

X6. STIMULANCIA

Xxxxxxx xxxxxxxxxxx (xxxxxx xxxx xxxxxx případných optických (X- x X-) xxxxxxx) jsou xxxxxxxx, x xxxxxxxx derivátů xxxxxxxxx v případě xxxxxx místního užití x xxxxxxxxxxx xxxxxxxxxx xx Monitorovacího xxxxxxxx xxx rok 2008.

Xxxxxxxxxxx zahrnují:

Xxxxxxxxx, xxxxxxxxx**, amfepramon, amfetaminil, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxxxxxxx, bromantan, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, etamivan, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, fenkamfamin, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, krotetamid, levmetamfetamin, xxxxxxxxx, mefentermin, xxxxxxxxxxxx, xxxxxxxxxxxx (X-), metylefedrin****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, methylfenidát, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, parahydroxyamfetamin, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, propylhexedrin, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, tuaminoheptan x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx příklady x xxxxx xxxxxx xxxx xxxxxxxxxx xx specifickou xxxxx xxxxx, xxxxx Xxxxxxxxx prokáže, xx xxxx xxxxxxxxx xxxxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx xx u xxx xxxxx pravděpodobnost, xx bude úspěšně xxxxxxxx jako xxxxxxxxx xxxxx.

S7. XXXXXXXXX

Xxxxxxxxxxx narkotika xxxx zakázaná:

Xxxxxxxxxxx, xxxxxxxxxxxxx, diamorfin(heroin), xxxxxxxx x xxxx xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

S8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, marihuana) xxxx xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx glukokortikosteroidy xxxxxxxx xxxxxx, rektálně, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx xxxx zakázané. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx výjimku.

Xxxx xxxxxxx xxxxxxxx xxxxxxxx (xxxxxxxxxxxx, xx xxxxx xxxxxx, do xxxxx xxxxxx, xxxxxxxxxx, xx xxxx) a xxxxxxxxx xxxxxxxx xxxxxxxx zkrácenou xxxxxxxxxxxxx xxxxxxx s xxxxxxxx xxxx xxxxxxxxx.

Xxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx xxxxx (xxxxxx iontoforézy/fonoforézy), xxxx, xxxxx, xxxx, xxxxxx xxxxx řitního otvoru, xxxxxxxx xxx x xxxxx nejsou zakázané x xxxxxxxxxx žádnou xxxxx xxxxxxxxxxxx xxxxxxx.

X1. XXXXXXX

Alkohol (etanol) xx zakázaný xxxxx Xxx xxxxxxx v xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx bude provádět xxxxxxxx xxxxxxxx a/nebo xxxxxxxx krve. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxxxxx (hematologická xxxxxxx) xx xxx xxxxxx xxxxxxxx xxxxxxx x xxxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (FIA) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx a xxxxxxxxxxxx (XXX) (0.20 g/l)

∙ Xxxxxxxxxxx (FITA, XXX) (0.10 x/x)

∙ Moderní pětiboj (XXXX) xxx xxx xxxxxxxxxx xx střelbou (0.10 x/x)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 g/l)

∙ Vodní motorismus (XXX) (0.30 x/x)

∙ Xxxxxxx (IPC) (0.10 g/l)

X2. BETA-BLOKÁTORY

Xxxxx xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Při xxxxxxx x xxxxxxxxxxxxx xxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Billiard (XXXX)

∙ Boby (XXXX)

∙ Xxxxx (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "match xxxx" - jen xxxxxxxxxxx

∙ Kuželky (XXX)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, IPC) (xxxxxxxx xxxx Xxxx soutěž)

∙ Lyžování (XXX) - xxxxx na xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx x U-rampa, x xxxxxxxxx X-xxxxx x "big air"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx xx xxxxxxxx

∙ Xxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx x xxxxxxx sporty (XXXX, XXX "xxxxx")

∙ Xxxxxxx (XXXX, XXX) (xxxxxxxx také Xxxx soutěž)

∙ Xxxxx xxxxxxxxxx (UIM)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, alprenolol, xxxxxxxx, betaxolol, bisoprolol, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, labetalol, xxxxxxxxxxx, metipranolol, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, pindolol, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx xx x xxxxxxxx pouze xx xx

"Xxxxxxxxxx látky"* xxxx vyjmenovány xxxx:

∙ Xxxxxxx Xxxx-2 xxxxxxxx x xxxxxxxx, xxxxx salbutamolu (volného xxxx xxxxxxxxxxx) při xxxxxxxx větším xxx 1000 xx/xx xxxx x xxxxxxxxxxxx (zařazen xx xxxxxxx X 1.2 Xxxxxxx xxxxxxxxxx xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, probenecid;

∙ Xxxxx, xxxxxxxxxxx, krotetamid, xxxxxxx, xxxxxxxx, famprofazon, xxxxxxxxxxxxx, xxxxxxxxxx, isomethepten, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, x-xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, sibutramin, xxxxxxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx neuvedená xxxxxxxx x xxxxxx X6, xxx xxxxx Xxxxxxxxx prokáže, xx xxxxxxx xxxxxxxx popsané x xxxxxx X6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Glukokortikosteroidy;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Xxxxxxx xxxxx být xxxxxxxxxxx xxxxxxxxxx xxxxx, které xxxxxxxx umožňuji neúmyslné xxxxxxxx xxxxxxxxxxxxxxx pravidel, xxxxxxx xxxx všeobecně xxxxxxxx v xxxxxxx xxxxxxxxx xxxxxxxxxxx, nebo x nichž je xxxxx xxxxxxxxxxxxxxx, že xxxxx xxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxxxx." Xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx takovéto xxxxx xxxx znamenat xxxxxxx xxxxxx za předpokladu, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, že Xxxxxxx xxxxxxxxxx látky xxxxxx xxxxxxxxx xx xxxxxxx xxxxxxxxxxx výkonu...".

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. xxxxx účinnosti xxxx 31.1.2008.

Xxxxxx předpis x. 2/2008 Xx. x. x. byl xxxxxx xxxxxxx předpisem č. 8/2009 Sb. m. s. x účinností od 7.2.2009.

Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx shora uvedeného xxxxxxxx xxxxxxxx.